Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange Detected- Added a government funding notice and operating status information for NIH Clinical Center, plus a new version tag v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check28 days agoChange DetectedPage now shows that results have been submitted and updates the revision to v3.1.0, replacing the previous state (No Results Posted, revision v3.0.2).SummaryDifference0.2%

- Check43 days agoChange DetectedPage updated to revision v3.0.2; a Back to Top link was removed. No significant changes to core content, pricing, stock, or time-based information.SummaryDifference0.2%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, particularly in Germany, South Korea, and Spain, while also removing previous location entries and some medical terminology related to drug classifications.SummaryDifference7%

- Check72 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.